Anteris Technologies Global (NASDAQ:AVR) Sets New 52-Week High – Should You Buy?

Anteris Technologies Global Corp. (NASDAQ:AVR)’s stock price reached a new 52-week high during trading on Tuesday . The stock traded as high as $10.21 and last traded at $10.1850, with a volume of 516497 shares changing hands. The stock had previously closed at $9.59.

Wall Street Analyst Weigh In

A number of analysts have weighed in on AVR shares. Cantor Fitzgerald restated an “overweight” rating and set a $15.00 target price on shares of Anteris Technologies Global in a report on Friday, March 27th. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Wells Fargo & Company started coverage on Anteris Technologies Global in a research note on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 target price on the stock. Barclays raised their price target on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Four research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $16.00.

Anteris Technologies Global Trading Up 8.0%

The stock has a 50-day simple moving average of $7.73 and a 200 day simple moving average of $6.31. The company has a market cap of $1.01 billion, a price-to-earnings ratio of -4.65 and a beta of 1.77.

Anteris Technologies Global (NASDAQ:AVR) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.The business had revenue of $0.49 million for the quarter, compared to analysts’ expectations of $0.77 million. During the same period in the prior year, the business posted ($0.61) earnings per share. As a group, research analysts forecast that Anteris Technologies Global Corp. will post -1.14 EPS for the current fiscal year.

Insider Transactions at Anteris Technologies Global

In other news, Director Susan Elizabeth Knight bought 11,000 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was purchased at an average cost of $9.29 per share, with a total value of $102,190.00. Following the acquisition, the director directly owned 11,000 shares in the company, valued at $102,190. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 4.50% of the company’s stock.

Hedge Funds Weigh In On Anteris Technologies Global

Hedge funds have recently bought and sold shares of the business. Militia Capital Management LLC acquired a new position in shares of Anteris Technologies Global during the 1st quarter worth approximately $3,663,000. Perceptive Advisors LLC increased its holdings in Anteris Technologies Global by 104.4% in the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock worth $19,011,000 after acquiring an additional 1,750,000 shares in the last quarter. Avidity Partners Management LP purchased a new stake in Anteris Technologies Global in the 1st quarter worth $832,000. Bank of America Corp DE raised its position in Anteris Technologies Global by 12.6% during the first quarter. Bank of America Corp DE now owns 68,755 shares of the company’s stock worth $382,000 after acquiring an additional 7,688 shares during the period. Finally, Anson Funds Management LP purchased a new position in Anteris Technologies Global during the first quarter valued at $1,126,000.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.